Patient Handling Equipment Market 2021-2026: Size, Trends, Share, Growth, Analysis and Forecast

april 22, 22 marketreserch

According to the latest report by IMARC Group, titled, “Patient Handling Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global patient handling equipment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026.

Patient handling equipment refers to tools and devices that provide mobility to patients who lack control of their bodies. They assist patients in sitting, standing, and walking while ensuring bed mobility, lateral transfers, and hoisting. Patient handling equipment also aid in minimizing the risk of complications, such as deep vein thrombosis, skin tears, chest infections, etc. They find numerous applications in intensive care units (ICUs), nursing homes, rehabilitation centers, etc., across the globe.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/patient-handling-equipment-market/requestsample

Market Trends

The growing geriatric population and the rising incidences of injuries caused during manual patient handling (MPH) are primarily driving the patient handling equipment market. Moreover, various government bodies across countries are implementing stringent regulations to encourage the adoption of protective equipment, which is also propelling the market growth. In addition to this, the increasing investments in hospital infrastructures to improve the overall patient handling capabilities of public healthcare systems are further bolstering the product demand. Additionally, the rising prevalence of disabilities among individuals is catalyzing the demand for patient lifting equipment, such as wheelchairs and mobile lifts. In the coming years, the rising integration of recent advancements, such as better bed frames, adjustable angles, shear and friction reduction, electric backrest, battery backups, support surfaces, etc., is expected to drive the global patient handling equipment market.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

EZ Way Inc.
Getinge AB
Guldmann Inc.
Hill-Rome Holdings Inc.
Invacare Corporation
Joerns Healthcare LLC
LINET Group SE
Medline Industries Inc.
Paramount Bed Co. Ltd.
Prism UK Medical Ltd
Stiegelmeyer GmbH & Co. KG
Stryker Corporation.

The report has segmented the market based on product, type of care and end user.

Breakup by Product:

Wheelchairs and Scooters
Medical Beds
Mechanical and Nonmechanical Equipment
Ambulatory Aids
Others

Breakup by Type of Care:

Bariatric Care
Fall Prevention
Critical Care
Wound Care
Others

Breakup by End User:

Hospital
Home Care Settings
Elderly Care Facilities
Others

Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/patient-handling-equipment-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

Ingen kommentarer

Business

marketreserch

Se indlæg

Anticoagulants Market Report, Trends, Share, Industry Size and Forecast 2021-2026

april 22, 22 marketreserch

According to the latest report by IMARC Group, titled, “Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global anticoagulants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026.

Blood clots form when blood thickens, forming a semi-solid mass in any part of the body. This can lead to severe health issues, such as heart attack, stroke, pulmonary embolism, transient ischemic attacks, deep vein thrombosis (DVT), etc. Owing to this, doctors prescribe anticoagulant drugs to people who are at a high risk of blood clot formation. These drugs aid in thinning blood, reducing or preventing blood clotting, and prolonging the clotting period. They are generally available in capsule or tablet form, including rivaroxaban, warfarin, dabigatran, apixaban, etc.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anticoagulants-market/requestsample

Market Trends

The sudden outbreak of the COVID-19 pandemic is leading to an increasing number of individuals becoming afflicted by hypercoagulability, which is becoming one of the biggest causes of mortality across the globe. This is catalyzing the demand for anticoagulant drugs to treat this thrombotic condition in critically ill or hospitalized patients. Moreover, the rising incidences of risk factors, such as trauma, extended sitting, smoking, blood disorders, autoimmune diseases, etc., that can cause blood clotting in various body parts are also augmenting the global market. Additionally, the growing prevalence of the human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, chronic inflammation, etc., is further propelling the market growth. Besides this, the improving diagnosis rates and the escalating need for target therapeutics are expected to fuel the anticoagulants market over the forecasted period.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Alexion Pharmaceuticals Inc
Aspen Holdings
Bayer AG
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Daiichi Sankyo Company Limited
Reddy’s Laboratories Ltd
GlaxoSmithKline plc
Johnson & Johnson Private Limited
Pfizer Inc.

The report has segmented the market based on drug class, route of administration, distribution channel and application.

Breakup by Drug Class:

Novel Oral Anticoagulants (NOACs)
Heparin and Low Molecular Weight Heparin (LMWH)
Vitamin K Antagonist
Others

Breakup by Route of Administration:

Oral Anticoagulant
Injectable Anticoagulant

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Stores
Others

Breakup by Application:

Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others

Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/anticoagulants-market

About Us

Contact us:

Ingen kommentarer

Business

marketreserch

Se indlæg

Ablation Devices Market Report, Trends, Share, Size, Growth and Forecast 2021-2026

april 22, 22 marketreserch

According to the latest report by IMARC Group, titled, “Ablation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global ablation devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026.

Ablation devices refer to minimally invasive (MI) medical instruments utilized for the excision or removal of abnormal body tissues for therapeutic purposes. Their commonly used variants include fluid-cooled, temperature-controlled, robotic catheter manipulation and laser ablators, balloon ablation devices, tissue contact and spray probes, etc. These devices operate using various technologies, such as hydrothermal, laser, cryoablation, microwave, ultrasound, etc. They find extensive applications in treating different disorders, including oncological, ophthalmological, gynecological, urological, cardiovascular, etc., as well as in managing several chronic diseases, removing kidney stones and cancerous tumors, managing chronic neck, lower back, and arthritis pain, etc.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/ablation-devices-market/requestsample

Market Trends

The surging prevalence of life-threatening diseases, such as cancer, atrial fibrillation, chronic venous insufficiency (CVI), etc., is among the primary factors driving the ablation devices market. Moreover, the growing public awareness towards the increasing availability of effective ablation procedures is further augmenting the product demand. Additionally, the rising adoption of electrophysiology to remove abnormal tissues that cause irregular heart rhythms or cardiac arrhythmia is bolstering the market growth. Furthermore, the development of various innovative products, such as next-generation ablation devices with robotic navigation systems, is also catalyzing the global market. Besides this, the introduction of non-thermal, non-tumescent, and non-sclerosant endovenous variants for effectively treating superficial vein reflux is expected to stimulate the ablation devices market over the forecasted period.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Abbott Laboratories
Angio Dynamics Inc.
AtriCure Inc.
Boston Scientific Corporation
CONMED Corporation
Elekta AB (publ)
Johnson & Johnson
Medtronic plc
Olympus Corporation
Smith & Nephew plc.

The report has segmented the market based on device technology, application and end user.

Breakup by Device Technology:

Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Others

Breakup by Application:

Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Others

Breakup by End User:

Hospital
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/ablation-devices-market

About Us

Contact us:

Ingen kommentarer

Business

marketreserch

Se indlæg

Microbiome Sequencing Services Market Report, Trends, Size, Share, Industry Analysis and Forecast 2021-2026

april 22, 22 marketreserch

According to the latest report by IMARC Group, titled, “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global microbiome sequencing services market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 21% during 2021-2026.

Microbiome sequencing services aid in determining the function of the microbiome in human health and disease pathogenesis by utilizing next-generation sequencing (NGS) instruments. They primarily include functional profiling, alpha-diversity, beta-diversity, virulence factor identification, LEfSe biomarker discovery, clustering heatmap, etc. These services offer comprehensive bioinformatics and statistical analyses in an interactive and user-friendly report, along with faster and more accurate classification compared to conventional identification methods, such as cloning and culturing.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/microbiome-sequencing-services-market/requestsample

Market Trends

The expanding pharmaceutical sector across the globe is among the key factors driving the microbiome sequencing services market. Moreover, the rising prevalence of colorectal cancer (CRC) owing to various factors, including the increasing occurrences of inflammatory intestinal conditions and consumption diets with low fiber and high fat content, is further stimulating the market growth. Apart from this, the escalating demand for early disease detection and diagnosis is further augmenting the global market. Furthermore, the growing applications of microbiome sequencing services in academia and research institutes for protein and small molecule analysis are catalyzing the product demand. Additionally, microbiome content is widely gaining traction as a biomarker for different diseases owing to faster and cost-effective sequencing platforms and data analysis pipelines, which is propelling the market. Besides this, the increasing focus on customizing gut microbial consortia to develop advanced individualized medicine, coupled with advancements in genomic research, are expected to drive the microbiome sequencing services market over the forecasted period.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

BaseClear B.V.
Clinical-Microbiomics A/S
Diversigen Inc (OraSure Technologies Inc.)
Mérieux NutriSciences
Metabiomics Corporation (BioSpherex LLC)
Microbiome Insights Inc.
Microbiome Therapeutics LLC
Molecular Research LP
Molzym GmbH & Co. KG
Resphera Biosciences LLC
Shanghai Realbio Technology (RBT) Co. Ltd.
Zymo Research Corporation.

The report has segmented the market based on technology, research type, laboratory type, application and end user.

Breakup by Technology:

Sequencing by Synthesis (SBS)
Sequencing by Ligation (SBL)
Pyrosequencing
Singer Sequencing
Others

Breakup by Research Type:

Outsourced Research
Internal Research

Breakup by Laboratory Type:

Dry Labs
Wet Labs

Breakup by Application:

Shotgun Sequencing
Targeted Gene Sequencing
RNA Sequencing
Whole Genome Sequencing
Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies
Research and Academic Institutes
Others

Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/microbiome-sequencing-services-market

About Us

Contact us:

Ingen kommentarer

Business

marketreserch

Se indlæg

Security Testing Market Report 2021: Growth, Size, Share, Analysis and Forecast 2026

april 22, 22 marketreserch

According to the latest report by IMARC Group, titled, “Security Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global security testing market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 25% during 2021-2026.

Security testing refers to a process utilized to identify loopholes and flaws in the security mechanisms that protect data and maintain the functionality of an information system. Such testing systems offer confidentiality, authentication, authorization, integrity, non-repudiation, etc. They also safeguard software, applications, data, resources, etc., against threats, malicious attacks, and vulnerabilities. Moreover, security testing aids in detecting possible security hazards that can lead to the loss of information or damage to an organization’s reputation. Some of the key areas of security testing include network, client-side application, system software, server-side application securities, etc.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/security-testing-market/requestsample

Market Trends

The sudden outbreak of the COVID-19 pandemic and the implementation of lockdowns across the globe are encouraging organizations to adopt remote working models for maintaining business continuity. In line with this, the growing security concerns, enabled by the increasing digitization of work functions and operations, are driving the security testing market. Additionally, the escalating threat of cybersecurity attacks resulting in substantial financial losses to individuals, enterprises, and government agencies, is also bolstering the product demand. Besides this, the growing prominence of online banking services and e-commerce platforms, coupled with the rising product demand from the banking, financial services, and insurance (BFSI) sector, is expected to drive the global security testing market over the forecasted period.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.